Company Filing History:
Years Active: 2011
Title: Yanick Bertrand: Innovator in Plasminogen Activation Regulation
Introduction
Yanick Bertrand is a notable inventor based in Longueuil, Canada. He has made significant contributions to the field of biomedical research, particularly in the regulation of plasminogen activation and cell migration. His innovative work has implications for treating various medical conditions, including cancer and thrombo-embolic diseases.
Latest Patents
Yanick Bertrand holds 1 patent for his invention titled "Compound and method for regulating plasminogen activation and cell migration." This invention relates to novel regulators of plasminogen activation and their use for regulating cell migration, plasminolysis, angiogenesis, and fibrinolysis. The patent outlines methods for treating cancer and thrombo-embolic diseases such as heart stroke. Specifically, it describes a method of regulating the activation of plasminogen by contacting a solution of pro-urokinase (uPA) or tissue plasminogen activator (tPA) and plasminogen with melanotransferrin (p97) for a time sufficient to effect regulation.
Career Highlights
Throughout his career, Yanick Bertrand has been associated with Transfert Plus, where he has focused on developing innovative solutions in the biomedical field. His work has garnered attention for its potential to improve therapeutic strategies for serious health conditions.
Collaborations
Yanick has collaborated with esteemed colleagues such as Richard Béliveau and Michel Demeule. These partnerships have contributed to the advancement of research in the areas of cell migration and plasminogen activation.
Conclusion
Yanick Bertrand's contributions to the field of plasminogen activation regulation highlight his role as an influential inventor. His innovative patent has the potential to impact the treatment of critical medical conditions, showcasing the importance of research and development in healthcare.